AzTrials
AzTrials

StrokeNCT04945356

Telerehabilitation During Pandemic Containment Measures of COVID19

A study testing upper limb training in people with Stroke, run by Université de Sherbrooke at 3 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

BACKGROUND: Although rehabilitation is effective in restoring function, many elderly individuals, especially those who have survived a stroke, are no longer receiving adequate rehabilitation services during the COVID19 pandemic due to containment measures. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
upper limb training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
3 sitesCanada
Study dates
28 Oct 2020to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • be over 18 years of age;
  • present a single unilateral stroke for more than 6 months;
  • have a minimal motor return to the upper limb assessed visually via the visuo-conference platform;
  • no longer receiving any in- or outpatient rehabilitation services.

Who cannot join

  • severe spasticity that prevents movement of the affected limb (score > 3 on the modified Ashworth scale);
  • an orthopedic problem with the affected upper limb or lower limb;
  • any neurological problem other than that arising from a stroke;
  • cognitive impairment (a score ≤ 2/5 on the Mini-Cog Test);
  • fall that has required physician evaluation within the past six months;
  • other neurologic, neuromuscular, or orthopedic disease or comorbidities that would prevent exercise participation or increase participant risk;
  • vision or hearing, communication, literacy or perceptual impairment that would interfere with app use as assessed by the study physical therapist during the screening process through a direct demonstration of the app and try out of the app

Trial locations and contacts

3 sites in 1 country.

Canada3 sites
  • Université du Québec à Chicoutimi

    Chicoutimi, Quebec, G7H 2B1

  • McGill University

    Montreal, Quebec

  • Centre de recherche sur le vieillissement

    Sherbrooke, Quebec, J1H4C4

Other trials in Canada

About this study

Official title: The Use of Telerehabilitation to Improve Function and Quality of Life for People in the Chronic Phase After Stroke During Pandemic Containment Measures of COVID19 : a Feasibility Pilot Study

BACKGROUND:

Although rehabilitation is effective in restoring function, many elderly individuals, especially those who have survived a stroke, are no longer receiving adequate rehabilitation services during the COVID19 pandemic due to containment measures. To overcome this problem, telerehabilitation is a promising avenue to deliver customized and personalized at-home therapy sessions while adhering to physical distancing guidelines.

Read more

OBJECTIVES:

The primary objective of this study is to evaluate the feasibility of using customized and personalized at-home therapy sessions using the Physiotec application for individuals with a stroke. A second objective is to measure the potential efficacy of the telerehabilitation intervention at improving function and quality of life based on standardized clinical measures and measures of improvement implemented in the Physiotec application.

METHODS:

We propose a non-randomized, single-group trial. Twenty-five individuals will be recruited on a voluntary basis. To be included, participants must 1) be ≥18 years old; 2) have a single unilateral stroke (≥ 6 months); 3) have minimal return of function in the affected upper limb; and 4) no longer be receiving rehabilitation treatments. Participants will receive a tablet containing the Physiotec application training program and TERA+, a telerehabilitation platform. The training program of the affected upper limb will last 6 weeks (90 minutes/week) and will be updated 3 times (weeks 1-3-5) by the therapist, using the TERA+ platform, based on the participant's functional capacity and progress, as measured by the app. Feasibility will be assessed by means of retention rate, adverse events, adherence to the telerehabilitation intervention, satisfaction with its use and with the exercise program. Efficacy will be assessed by several questionnaires on life habits, motor recovery and quality of life.

RELEVANCE:

This study will inform as to the optimal delivery of adapted rehabilitation services for stroke survivors that are currently not receiving optimal rehabilitation services because of the ongoing COVID19 pandemic. The results will serve to support in-home rehabilitation exercises aimed at promoting recovery, independent living and improving quality of life for stroke survivors.

Conditions
Stroke
Being tested
upper limb training
Keywords
stroke, telerehabilitation, COVID19, function, upper limb, quality of life
Medical subject headings
Stroke, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • upper limb trainingOther

    The 6-week exercise program will consist of evidence-based exercises covering the breadth and depth of rehabilitation interventions. The therapist will choose the appropriate exercises for each participant's level of function from more than 15,000 exercises implemented within the Physiotec app and developed by rehabilitation experts. Personalized upper limb exercises will be based on the therapist initial assessment of participants, using the TERA+ telerehabilitation platform, and their goals. After each training session, participants will have to rate their perceived level of effort on a Borg scale (/10). The Borg scores will be monitored by the therapist as a precautionary measure to ensure safety and appropriateness of intensity of exercises. Participants will be instructed to train at a target score of around 7/10 (somewhat hard) on the Borg scale.

Study groups in NCT04945356
Study groupRoleWhat they receive
upper limb virtual trainingExperimental6-week virtual training of the affected upper limb using the Physiotec application
Receives: Other: upper limb training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Retention rate to the telerehabilitation intervention

    the number of participants enrolled at the end of the study divided by the number of participants recruited at the beginning of the study

    Measured: in the week after the last session of telerehabilitation training

  2. Adherence to the telerehabilitation training program

    the number of telerehabilitation training sessions that participants took part in during the 6-week training program

    Measured: in the week after the last session of telerehabilitation training

  3. Adverse events related to the intensity of training assessed with the Borg scale embedded within the Physiotec application

    Adverse events related to the intensity of training will be tracked after each training session via the BORG scale (intensity of training should not be done at a score higher than 7/10)

    Measured: after each training session throughout the duration of the telerehabilitation training program

  4. Adverse events related to pain levels assessed with the visual analog scale embedded within the Physiotec application

    Adverse events related to pain will be tracked after each training session with a 0-10 visual analog scale for pain (training will be adjusted if pain score is greater than 7/10).

    Measured: after each training session throughout the duration of the telerehabilitation training program

  5. Participants' satisfaction with telerehabilitation assessed with the Telerehabilitation Satisfaction questionnaire

    Telerehabilitation Satisfaction questionnaire: this questionnaire contains 15 questions where the participants rate their satisfaction about the use of telerehabilitation on a Likert scale (from strongly agree to strongly disagree or undecided).

    Measured: in the week after the last session of telerehabilitation training

  6. Participants' satisfaction with the application assessed with the User Satisfaction questionnaire

    User Satisfaction questionnaire: this questionnaire contains 6 questions about the participants satisfaction about the application (from 1 = not at all to 5 = extremely)

    Measured: in the week after the last session of telerehabilitation training

  7. Participants' satisfaction with the exercise program assessed with the Health Care Satisfaction questionnaire

    Health Care Satisfaction questionnaire: this questionnaire comprises 26 questions about the participants feeling (from 1= not at all to 4= extremely) and the importance they give to different situations (from 1= not important to 4 = extremely important) related to the training program

    Measured: in the week after the last session of telerehabilitation training

Secondary outcomes (8)
  1. Change in quality of life assessed with the 12-item Short Form Survey

    SF-12: this 12-question health survey assesses both physical and mental components of the respondent's current health status compared to their health status one month ago. It covers 8 domains such as limitations in physical activities because of health problems and bodily pain. Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.

    Measured: baseline and in the week after the last session of telerehabilitation training

  2. Change in life habits assessed with the LIFE-H 3.0 questionnaire

    LIFE-H 3.0: this test includes 240 items and assesses the level of participation in daily activities and social roles. It also considers the degree of difficulty in carrying out tasks as well as the type of assistance required by the person. Each question is scored on a 0-9 scale where a score of 0 implies a total disruption of participation.

    Measured: baseline and in the week after the last session of telerehabilitation training

  3. Change in the quantity and quality of affected upper limb use assessed with the Motor Activity Log

    Motor Activity Log-14: this questionnaire assesses, on a 6-point ordinal scale, the use and quality of use of the affected upper limb in 14 everyday activities. A high score means that the participant perceives a greater use of his arm and a better quality of movement.

    Measured: baseline and in the week after the last session of telerehabilitation training

  4. Change in reintegration to social activities assessed with the Reintegration to Normal Living Index

    Reintegration to Normal Living Index: this questionnaire covers the following domains: indoor, community, distance mobility, self-care, daily activity, recreational and social activities, family role(s), personal relationships, presentation of self to others and general coping skills. Using 11 questions, it quantitatively assesses, on a 0-10 cm visual analogue scale, the degree to which individuals achieve reintegration into normal living. Each score is summed to provide a total score out of 110 points (adjusted back to 100) where a higher score indicates a better perception of reintegration

    Measured: baseline and in the week after the last session of telerehabilitation training

  5. Change in motor recovery of affected upper limb assessed with the Stroke Rehabilitation Assessment of Movement

    Stroke Rehabilitation Assessment of Movement: it is a performance-based measure that evaluates, on a 3-point ordinal scale, motor recovery at the affected upper limb. The total score for the upper limb section is 20 points with a higher score indicating a better motor recovery.

    Measured: baseline and in the week after the last session of telerehabilitation training

  6. Change in range of motion at the affected upper limb assessed visually

    Range of motion of the upper extremity will be visually estimated by a research assistant, using the TERA+ platform, for the shoulder (flexion), elbow (flexion \& extension), forearm pronation/supination, wrist (extension \& flexion) and finger (flexion \& extension).

    Measured: baseline and in the week after the last session of telerehabilitation training

  7. Participants' perceived improvement of the affected upper limb following training assessed with the Global Rating of Change Score questionnaire

    Global Rating of Change Score: this questionnaire will assess the participant's perceived improvement in the function of his trained upper limb on a 7-point ordinal scale from 3 (very much improved) to -3 (very much worse)

    Measured: in the week after the last session of telerehabilitation training

  8. Fear of COVID assessed with the Fear of COVID-19 scale

    Fear of COVID-19 scale: this 7-item questionnaire will assess the perception of the participants about the COVID19 pandemic using a five-item Likert- type scale (from "strongly disagree" to "strongly agree"). The minimum score possible for each question is 1, and the maximum is 5. A total score is calculated by adding up each item score. The higher the score, the greater the fear of coronavirus-19 is.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2021
  2. Study start28 Oct 2020
  3. Primary completion31 Oct 2021
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04945356
Sponsor's protocol ID
MP-31-2021-3817
Status last verified
Apr 2022
First submitted
24 Jun 2021
Last updated
27 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing upper limb training in people with Stroke, run by Université de Sherbrooke at 3 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Retention rate to the telerehabilitation intervention (time frame: in the week after the last session of telerehabilitation training). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in